AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19752483 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 108
Study 19752483 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 108
Study 17207671 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded sit-to-stand (STS) resistance exercise 3 times a week for 6 weeks
Number of subjects: 20
Study 17207671 — intervention group
Group type: COMPARATOR
Intervention: Regular physical therapy
Number of subjects: 20
Study 15121054 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal males (G1) with strong spectral pattern and high complexity
Number of subjects: 119
Study 15121054 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal males (G2) with weak spectral pattern and low complexity
Number of subjects: 119
Study 15121054 — intervention group
Group type: COMPARATOR
Intervention: Larynx cancer cases (post-irradiation)
Number of subjects: 119
Study 11549680 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon-like peptide-1 (7-36) amide infusion
Number of subjects: 115
Study 9702436 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 30
Study 9702436 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 30
Study 7977878 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 64
Study 7977878 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 64
Study 2610663 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.85 g/kg)
Number of subjects: 0
Study 2610663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 337865 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid
Number of subjects: 25000
Study 337865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25000
Study 31102331 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindray BC‐6800 hematology analyzer
Number of subjects: 101
Study 31102331 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminative scoring system (SS) based on automated BM counts
Number of subjects: 101
Study 31102331 — intervention group
Group type: COMPARATOR
Intervention: Comparison set using Advia 2120 and CELL‐DYN Sapphire analyzers
Number of subjects: 101
Study 28503739 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental brushes (Group A)
Number of subjects: 108
Study 28503739 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental floss (Group C)
Number of subjects: 108
Study 28503739 — intervention group
Group type: COMPARATOR
Intervention: No interdental hygiene (Group B)
Number of subjects: 108
Study 26314489 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Valsalva manoeuvre (semi‐recumbent with supine repositioning and passive leg raise immediately after the Valsalva strain)
Number of subjects: 433
Study 26314489 — intervention group
Group type: COMPARATOR
Intervention: Standard semi‐recumbent Valsalva manoeuvre
Number of subjects: 433
Study 23243254 — intervention group
Group type: COMPARATOR
Intervention: Vitamin E (10 mg•kg(‐1) of feed; VE‐10)
Number of subjects: 60
Study 23243254 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (100 mg•kg(‐1) of feed; VE‐100)
Number of subjects: 60
Study 23243254 — intervention group
Group type: EXPERIMENTAL
Intervention: Oregano essential oil (100 mg•kg(‐1) of feed; OR‐100)
Number of subjects: 60
Study 23243254 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey (3%) added to meat
Number of subjects: 60
Study 23243254 — intervention group
Group type: EXPERIMENTAL
Intervention: Butylated hydroxytoluene (0.02%; BHT) added to meat
Number of subjects: 60
Study 21411715 — intervention group
Group type: EXPERIMENTAL
Intervention: Real repetitive lumbosacral magnetic stimulation (rLMS; 15 Hz with a total of 1500 pulses/session) for 10 sessions
Number of subjects: 0
Study 21411715 — intervention group
Group type: COMPARATOR
Intervention: Sham repetitive lumbosacral magnetic stimulation
Number of subjects: 0
Study 21411715 — intervention group
Group type: EXPERIMENTAL
Intervention: Real repetitive lumbosacral magnetic stimulation (rLMS)
Number of subjects: 0
Study 19336657 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glulisine
Number of subjects: 0
Study 19336657 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin
Number of subjects: 0
Study 19336657 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart
Number of subjects: 0
Study 19336657 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro
Number of subjects: 0
Study 17237494 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing (AD) method
Number of subjects: 819777
Study 17237494 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem‐based learning (PBL) method
Number of subjects: 819777
Study 17237494 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 819777
Study 15172395 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site primary angioplasty (PA)
Number of subjects: 571
Study 15172395 — intervention group
Group type: COMPARATOR
Intervention: Transfer for primary angioplasty (PA)
Number of subjects: 571
Study 11289700 — intervention group
Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU) 3 x 100 mg/d for 30 d
Number of subjects: 27
Study 11289700 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study 9124328 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW
Number of subjects: 6
Study 9124328 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW+BCAA
Number of subjects: 6
Study 9124328 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 6
Study 7946585 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate plus lonidamine (MTX + LND)
Number of subjects: 89
Study 7946585 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate alone (MTX)
Number of subjects: 89
Study 3607818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrethrin-piperonyl-butoxide shampoo
Number of subjects: 40
Study 3607818 — intervention group
Group type: COMPARATOR
Intervention: Pyrethrin-piperonyl-butoxide lotion
Number of subjects: 40
Study 29289531 — intervention group
Group type: EXPERIMENTAL
Intervention: GSR biofeedback therapy
Number of subjects: 40
Study 29289531 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 40
Study 26551986 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin arm (atorvastatin 80 mg/10 mg or simvastatin 20 mg)
Number of subjects: 13937
Study 25615992 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiz game format
Number of subjects: 66
Study 25615992 — intervention group
Group type: COMPARATOR
Intervention: Didactic lecture format
Number of subjects: 66
Study 23994935 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (melaxen)
Number of subjects: 30
Study 20934571 — intervention group
Group type: EXPERIMENTAL
Intervention: Any hospital admission
Number of subjects: 933
Study 18847464 — intervention group
Group type: EXPERIMENTAL
Intervention: Turkish version of the adapted leaflet
Number of subjects: 57
Study 18847464 — intervention group
Group type: COMPARATOR
Intervention: Original German leaflet
Number of subjects: 57
Study 16618298 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh autologous whole blood (15 ml x kg(‐1) collected prior to heparinization)
Number of subjects: 32
Study 16618298 — intervention group
Group type: COMPARATOR
Intervention: 5% albumin (15 ml x kg(‐1) infused intravenously)
Number of subjects: 32
Study 16618298 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh autologous whole blood
Number of subjects: 32
Study 12746768 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 896
Study 12746768 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin
Number of subjects: 896
Study 10764420 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + CT
Number of subjects: 243
Study 10764420 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 243
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate
Number of subjects: 80
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% tropicamide
Number of subjects: 80
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine
Number of subjects: 80
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate and 1% tropicamide
Number of subjects: 80
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine and 1% tropicamide
Number of subjects: 80
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% cyclopentolate, 0.5% tropicamide and 2.5% phenylephrine
Number of subjects: 80
Study 8823596 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% cyclopentolate and 2.5% phenylephrine
Number of subjects: 80
Study 8823596 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 80
Study 1483442 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese group
Number of subjects: 23
Study 1483442 — intervention group
Group type: COMPARATOR
Intervention: Nonobese group
Number of subjects: 23
Study 4016054 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 26
Study 4016054 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hyaluronate plus systemic acetazolamide
Number of subjects: 26
Study 4016054 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 26
Study 4016054 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 26
Study 31096123 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (EXT)
Number of subjects: 50
Study 31096123 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (EXT) after resuming habitual sleep
Number of subjects: 50
Study 29143484 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg d‐1 folate after 4 weeks
Number of subjects: 119
Study 29143484 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg d‐1 folate after 4 weeks
Number of subjects: 119
Study 29143484 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg d‐1 folate after 8 weeks
Number of subjects: 119
Study 29143484 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg d‐1 folate after 8 weeks
Number of subjects: 119
Study 26381715 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (mildly pre-eclamptic mothers' fetuses)
Number of subjects: 73
Study 26381715 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III (severe pre-eclamptic mothers' fetuses)
Number of subjects: 73
Study 26381715 — intervention group
Group type: COMPARATOR
Intervention: Group I (healthy mothers' fetuses)
Number of subjects: 73
Study 26381715 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 73
Study 25354015 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily online tube potential‐cone beam CT (CBCT) image guidance with reduced CTV2 to PTV2 margins (3 mm)
Number of subjects: 18
Study 25354015 — intervention group
Group type: COMPARATOR
Intervention: Standard 5-mm CTV2 to PTV2 margin
Number of subjects: 18
Study 22167005 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure transvaginal appendectomy (TVA)
Number of subjects: 40
Study 22167005 — intervention group
Group type: COMPARATOR
Intervention: Traditional laparoscopic appendectomy (LA)
Number of subjects: 40
Study 20460360 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg)
Number of subjects: 40
Study 20460360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 17880774 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamphenicol glycinate acetylcisteinate (TGA) 500 mg b.i.d. intramuscularly on the first day and TGA 500 mg b.i.d. by aerosol during the following days (n=151)
Number of subjects: 817
Study 17880774 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamphenicol glycinate acetylcisteinate (TGA) 250 mg b.i.d. by aerosol (n=149)
Number of subjects: 817
Study 17880774 — intervention group
Group type: COMPARATOR
Intervention: Other standard antibiotics given intramuscularly (n=268)
Number of subjects: 817
Study 17880774 — intervention group
Group type: COMPARATOR
Intervention: Other standard antibiotics given orally (n=249)
Number of subjects: 817
Study 17880774 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamphenicol glycinate acetylcisteinate (TGA)
Number of subjects: 817
Study 16627794 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (perindopril for all, plus indapamide for some)
Number of subjects: 6105
Study 14596362 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 8/16mg
Number of subjects: 19
Study 14596362 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 19
Study 14596362 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 8/16mg and Hydrochlorothiazide 12.5 mg (combination)
Number of subjects: 19
Study 14596362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 10953904 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction (limb position instructions)
Number of subjects: 80
Study 10953904 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory cue (listen to impact sounds)
Number of subjects: 80
Study 10953904 — intervention group
Group type: COMPARATOR
Intervention: Imagery (metaphorical)
Number of subjects: 80
Study 10953904 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 8612863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreservation of all embryos (n = 13)
Number of subjects: 26
Study 8612863 — intervention group
Group type: COMPARATOR
Intervention: IV infusions of albumin (n = 13)
Number of subjects: 26
Study 8612863 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreservation of all embryos
Number of subjects: 26
Study 8612863 — intervention group
Group type: COMPARATOR
Intervention: IV infusions of albumin
Number of subjects: 26
Study 1295286 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinaverium bromide (50 mg, two tablets)
Number of subjects: 32
Study 1295286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 6540581 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg orally)
Number of subjects: 18
Study 30724746 — intervention group
Group type: EXPERIMENTAL
Intervention: New incontinence containment product
Number of subjects: 12
Study 30724746 — intervention group
Group type: COMPARATOR
Intervention: Premium adult diaper (control)
Number of subjects: 12
Study 27341088 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric warm-up and high-intensity plyometric protocol
Number of subjects: 32
Study 27341088 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 32
Study 26012640 — intervention group
Group type: EXPERIMENTAL
Intervention: Top tertile of soluble CD40L levels
Number of subjects: 3044
Study 26012640 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated levels of sCD40L and high-sensitive C-reactive protein
Number of subjects: 3044
Study 24595306 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH exercise trial (30 min at 60% Wmax)
Number of subjects: 8
Study 24595306 — intervention group
Group type: COMPARATOR
Intervention: LOW exercise trial (60 min at 30% Wmax)
Number of subjects: 8
Study 22525955 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint attention intervention group
Number of subjects: 40
Study 22525955 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbolic play intervention group
Number of subjects: 40
Study 22525955 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline play diversity
Number of subjects: 40
Study 19950090 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg orally for the first four days
Number of subjects: 31
Study 19950090 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg orally from the fifth to the eighth day
Number of subjects: 31
Study 19950090 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 31
Study 17543743 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 215
Study 17543743 — intervention group
Group type: COMPARATOR
Intervention: Control group (primary percutaneous coronary intervention without thrombectomy)
Number of subjects: 215
Study 15093878 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 2289
Study 15093878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2289
Study 11251731 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki Touch therapy
Number of subjects: 23
Study 9444543 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (8-week treatment)
Number of subjects: 0
Study 9444543 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8-week treatment)
Number of subjects: 0
Study 7936522 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge with nurse specialist home follow-up care
Number of subjects: 122
Study 7936522 — intervention group
Group type: COMPARATOR
Intervention: Usual discharge care
Number of subjects: 122
Study 3315602 — intervention group
Group type: EXPERIMENTAL
Intervention: Anisoylated plasminogen streptokinase activator complex (APSAC; 30U)
Number of subjects: 54
Study 3315602 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary streptokinase (250,000U)
Number of subjects: 54
Study 30249337 — intervention group
Group type: EXPERIMENTAL
Intervention: Threat condition
Number of subjects: 102
Study 30249337 — intervention group
Group type: COMPARATOR
Intervention: No-threat condition
Number of subjects: 102
Study 25854771 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 20
Study 25854771 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic Stretching (CS)
Number of subjects: 20
Study 25854771 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 25619549 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of an oral loop diuretic at discharge
Number of subjects: 6119
Study 25619549 — intervention group
Group type: COMPARATOR
Intervention: Change in loop diuretic dose at discharge for patients already established on diuretics prior to admission
Number of subjects: 6119
Study 23434222 — intervention group
Group type: EXPERIMENTAL
Intervention: New fertilization method with decreasing number of spermatozoa
Number of subjects: 0
Study 23434222 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard fertilization method)
Number of subjects: 0
Study 21180238 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 meters walking test (400mWT)
Number of subjects: 20
Study 21180238 — intervention group
Group type: COMPARATOR
Intervention: 6 minutes walking test (6MWT)
Number of subjects: 20
Study 21180238 — intervention group
Group type: COMPARATOR
Intervention: Cycloergometer exercise stress test
Number of subjects: 20
Study 18389313 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity mechanical port applier fixation (group A)
Number of subjects: 50
Study 18389313 — intervention group
Group type: COMPARATOR
Intervention: Titanium suture-fixation port (group B)
Number of subjects: 50
Study 16446318 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alkylating chemotherapy (cyclophosphamide, thiotepa and carboplatin)
Number of subjects: 621
Study 16446318 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (FEC followed by radiation therapy and tamoxifen)
Number of subjects: 621
Study 12582945 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (60 mg four times daily)
Number of subjects: 8
Study 12582945 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine (25 mg four times daily)
Number of subjects: 8
Study 12582945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12582945 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine
Number of subjects: 8
Study 12582945 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine
Number of subjects: 8
Study 11432680 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single preoperative dose)
Number of subjects: 808
Study 11432680 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 808
Study 9410681 — intervention group
Group type: EXPERIMENTAL
Intervention: Open access laparoscopic surgery
Number of subjects: 50
Study 9410681 — intervention group
Group type: COMPARATOR
Intervention: Veress needle technique
Number of subjects: 50
Study 8415806 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose oil (4 g), sardine oil (2.4 g), vitamin E (200 mg) for 4 weeks
Number of subjects: 18
Study 8415806 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose oil and fish oil treatment
Number of subjects: 18
Study 8415806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oils)
Number of subjects: 18
Study 2877480 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment for hypertension
Number of subjects: 2000
Study 2877480 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study 30772789 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 599
Study 28282796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level continuous heat (LLCH)
Number of subjects: 92
Study 28282796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level continuous heat with Ibuprofen (LLCH + IP)
Number of subjects: 92
Study 28282796 — intervention group
Group type: COMPARATOR
Intervention: Sham LLCH with sham Ibuprofen
Number of subjects: 92
Study 28282796 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 25075645 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cream 1
Number of subjects: 0
Study 25075645 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cream 2
Number of subjects: 0
Study 23356673 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient Foley catheter (OPC)
Number of subjects: 101
Study 23356673 — intervention group
Group type: COMPARATOR
Intervention: Inpatient vaginal PGE2 (IP)
Number of subjects: 101
Study 21610557 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume ultrasound-guided ankle block (16 mL ropivacaine 0.5%)
Number of subjects: 72
Study 21610557 — intervention group
Group type: COMPARATOR
Intervention: Conventional-volume surface landmark technique (30 mL ropivacaine 0.5%)
Number of subjects: 72